TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alkem Laboratories Ltd. ( (IN:ALKEM) ) has provided an update.
Alkem Laboratories Ltd. reported an 11% increase in revenue and a 22% rise in net profit for Q1 FY26, driven by strong growth in both domestic and international sales. The company achieved a higher EBITDA margin and outperformed the Indian Pharmaceutical Market in terms of growth, reflecting its strategic focus on value-accretive products and markets.
More about Alkem Laboratories Ltd.
Alkem Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical products. The company has a significant presence in both domestic and international markets, with a strategic emphasis on expanding in high-potential non-US markets.
Average Trading Volume: 44,162
Technical Sentiment Signal: Sell
Current Market Cap: 579B INR
Find detailed analytics on ALKEM stock on TipRanks’ Stock Analysis page.